Lindbrook Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Lindbrook Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-172	Closed	-$12K	–	3082
2022 Q3	$12K	Buy	172 +122	+244%	+$6.73K	﹤0.01%	1263
2022 Q2	$2K	Buy	50 +23	+85%	+$673	﹤0.01%	2111
2022 Q1	$1K	Buy	+27	New	+$807	﹤0.01%	2445
2021 Q2	–	Sell	-94	Closed	-$4K	–	2027
2021 Q1	$4K	Buy	+94	New	+$4.32K	﹤0.01%	1373
2019 Q4	–	Sell	-700	Closed	-$34K	–	1567
2019 Q3	$34K	Buy	700 +400	+133%	+$20.8K	0.01%	541
2019 Q2	$15K	Sell	300 -450	-60%	-$25.9K	0.01%	787
2019 Q1	$39K	Sell	750 -600	-44%	-$29.5K	0.02%	494
2018 Q4	$55K	Buy	+1,350	New	+$50.6K	0.03%	313

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's GBT Position: Q4 2022 in Review

Lindbrook Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 172 shares — an estimated $12K sold.

Lindbrook Capital first reported a position in GBT in Q4 2018 and held it in 8 quarters. The position peaked at $55K in Q4 2018. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Lindbrook Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Lindbrook Capital sold 172 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $12K.
Lindbrook Capital first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 8 quarters.
Lindbrook Capital's Global Blood Therapeutics, Inc. position peaked at $55K in Q4 2018.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.